6 February 2018
Sofitel Legend Amsterdam The Grand
If you are interested in sponsoring the 2017 BioCapital Europe Conference please contact firstname.lastname@example.org or call +44 020 7250 7050
Event Organised by
LSP (Life Sciences Partners)
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
For more information, please visit lspvc.com.
Gold Sponsors 2017
LifeSci Advisors, LLC (www.lifesciadvisors.com) is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. With a local presence in New York, Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv, the firm provides the highest quality service for its clients through its deep sector specialization. Our roster of PhDs enables us to better understand our clients’ R&D, regulatory, and commercial strategy, and our team of capital markets, investor relations, and public relations specialists help our clients effectively communicate to the marketplace. This combination of life sciences, capital markets, and investor relations competencies allows us to provide a valuable and highly differentiated service offering to our clients.
Euronext is the leading pan-European exchange in the Euro zone with more than 1 300 listed issuers worth close to €3.1 trillion in market capitalization as of end October 2016, an unmatched blue chip franchise consisting of 25 issuers in the EURO STOXX 50® benchmark and a strong diverse domestic and international client base.
Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. Euronext operates regulated markets, Alternext and the Free Market; in addition it offers EnterNext, which facilitates SMEs’ access to capital markets.
Imagine the strength of nearly 180,000 people who focus on building relationships across the globe each and every day. Not only with clients, but also with each other. And just imagine how much value those relationships could create together. We prove our added value by looking further than just the figures and by being responsive to personal goals and ambitions. By investing in each other, we reinforce our relationship. In doing so, we enhance the value of our network at the BioCapital Europe conference, and the impact we can make together.
Lunch Sponsor 2016
Coulter Partners is a board and senior level global executive search specialist focused exclusively on Life Sciences. We work closely with those at the cutting edge of innovation in the industry in order to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, we have become trusted advisers on leadership in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors. We also work with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolios companies. The largest dedicated Life Science search boutique in North America and Europe, we work in a unique way. We share knowledge and connections across the globe, as one team with one goal. To bring clients the world’s best talent.
Tea & Coffee Breaks Sponsor 2016
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
How EY’s Global Life Sciences Sector can help your business
Life sciences companies — from emerging start-ups to multinational enterprises — face new challenges in a rapidly changing health care ecosystem. Payers and regulators are increasing scrutiny and accelerating the transition to value and outcomes. Big data and patient-empowering technologies are driving new approaches and enabling transparency and consumerism. Players from other sectors are entering health care, making collaborations increasingly complex. These trends challenge every aspect of the life sciences business model, from R&D to marketing.
Our Global Life Sciences Sector brings together a worldwide network — more than 7,000 sector-focused assurance, tax, transaction and advisory professionals — to anticipate trends, identify their implications and develop points of view on responding to critical issues. We can help you navigate your way forward and achieve success in the new ecosystem.
Drinks Reception Sponsor 2017
Loyens & Loeff
Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance.
Thanks to our closely collaborating legal and tax practices, we have built up a unique and very solid position in the market. With about 1600 employees worldwide, consisting of about 400 tax experts and about the same number of legal experts, we are capable of effectively structuring and supervising both domestic and international matters. We provide services from our six Benelux offices and from our eleven branches based in the world’s major financial centres.
Contributing Sponsors 2017
Allen & Overy
Allen & Overy Amsterdam is known for its individual experts and their ability to join forces, across practice areas and borders, to get deals done and to find solutions in highly complex cases. We are universally recognised market leaders in corporate transactions, banking & capital markets, governance & regulatory and disputes. Our global span of 44 offices with over 5,200 people and 530 partners covers established and emerging economies in the West and East and contains a network of over 90 highly experienced lawyers in life sciences. We act for companies and their investors across the industry, including pharmaceutical, biotechnology, medtech, diagnostics and healthcare sectors.
De Breij Evers Boon
The firm: De Breij Evers Boon is a Dutch corporate law boutique firm. It was founded in 2005 at the initiative of Dennis de Breij, Marcel Evers and Joris Boon, all of whom worked at De Brauw Blackstone Westbroek at that time. Shared ideas about a corporate law practice with maximum added value for clients has been the primary motivation for them to join forces. Nowadays, The firm consists of 18 specialist lawyers, strengthened by experienced senior lawyers from Freshfields, Allen & Overy and Baker McKenzie. The firm combines a corporate law boutique approach, dedication, services and fees, with big firm quality, experience, processing and execution power. De Breij Evers Boon has distinguished itself in the Dutch market and continues to aim for further development in these areas.
Areas of practice: De Breij Evers Boon focuses exclusively on corporate law transactions, litigation and advice. Amongst its clients are key players in the fields of banking, media, renewable energy, retail and private equity/venture capital, but also other types of industry. Besides corporate clients, its clients typically also include experienced entrepreneurs, founders, angel investors and other advisors.
Dechert is a global specialist law firm.
Focused on sectors with the greatest complexities, legal intricacies and highest regulatory demands, we excel at delivering practical commercial judgment and deep legal expertise for high-stakes matters.
In an increasingly challenging environment, clients look to us to serve them in ways that are faster, sharper and leaner without compromising excellence.
We are relentless in serving our clients – delivering the best of the firm to them with entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
Eversheds Sutherland in the Netherlands is an established practice of lawyers and civil law notaries with offices in Amsterdam and Rotterdam. We are a full service business law firm with specialist expertise in areas including corporate law and M&A, commercial agreements, employment and labour law, banking and finance, real estate, antitrust & EU law, disputes and litigation, information technology and intellectual property. We are part of Eversheds Sutherland International, one of the world’s leading international law firms. The Life Sciences Group of EvershedsSutherland is a highly recommended, multi-disciplinary legal team with extensive experience of the issues faced by the different sectors of the pharmaceutical, biosciences and medical devices industries. Specialists across the Group have extensive experience of the issues faced by the international biomedical industry with patent specialists across the world providing cutting-edge advice to the life sciences sector. Our Life Sciences Group is highly integrated and are able to advise you in multiple jurisdictions.
Panel Sponsors 2017
Bank Degroof Petercam is a reference independent financial institution, serving private, institutional investors and organizations, based on a history dating back to 1871.
Headquartered in Brussels, we employ 1 400 professionals through offices in Belgium, Luxemburg, France, Switzerland, Spain, The Netherlands, Germany, Italy, and Hong Kong.
Our clients benefit from best in-class services through the unique combination of private banking, institutional asset management , investment banking (corporate finance and financial intermediation) and asset services.
We manage assets of ca 50 billion euro for private investors and families, corporates, public and corporate pension funds, insurance companies, governmental and non-profit organizations.
KBC Securities is the leading domestic debt equity house in the core markets of the KBC Group. We focus on both institutional and retail customers. We specialize in Institutional Brokerage, Retail Brokerage, Securities Services, M&A, Debt/Equity Capital Markets and Debt & Equity Research. Building long-term client relationships is key to our business. KBC Securities creates added value through a thorough knowledge of its local markets and companies, by offering both local as well as cross border solutions. KBC Securities is present in Belgium and selected East European countries with a specific focus on Small & Mid Cap Companies. For more information, please visit: www.kbcsecurities.com.
KBC Group, our parent company, is an integrated bancassurance group, catering mainly for retail, SME and midcap customers. It concentrates on its home markets of Belgium and certain countries in Central and Eastern Europe. Elsewhere around the globe, the group has established a presence in selected countries and regions.
KBC Securities was awarded in 2016 No 1. Equity Finance House and Belgian SME Brokerage House .
Kempen & Co
Since its foundation in 1903, Kempen & Co is an investment bank offering first-class corporate finance and securities brokerage through personal and long-lasting relationships with clients, including corporates, institutional investors, financial institutions and financial sponsors.
Numerous innovative and growth-companies in life sciences & healthcare are using public capital markets as their primary source of capital to fund research and development. Many of them also view a “buy and build strategy” as an accelerator for growth. Kempen & Co has built a strong international position in both M&A and equity capital market transactions. We facilitate cross-border acquisitions between large and small innovative companies and support international capital market transactions based on a wealth of sector experience and a global investor network.
Our specialists look forward to share experience and network to support the growth of innovative and entrepreneurial companies.